Earnings summaries and quarterly performance for COMMUNITY HEALTH SYSTEMS.
Executive leadership at COMMUNITY HEALTH SYSTEMS.
Kevin J. Hammons
Interim Chief Executive Officer
Chad A. Campbell
Regional President – Region 2 Operations
Jason K. Johnson
Interim Chief Financial Officer
Justin D. Pitt
President and Chief Legal and Administrative Officer
Kevin A. Stockton
Executive Vice President of Operations and Development
Mark B. Medley
Regional President – Region 3 Operations
Board of directors at COMMUNITY HEALTH SYSTEMS.
Elizabeth T. Hirsch
Director
Fawn D. Lopez
Director
H. James Williams, Ph.D.
Director
James S. Ely III
Director
John A. Clerico
Lead Independent Director
John A. Fry
Director
Joseph A. Hastings, D.M.D.
Director
K. Ranga Krishnan, MBBS
Director
Michael Dinkins
Director
Ronald L. Burgess, Jr.
Director
Susan W. Brooks
Director
Wayne T. Smith
Chairman of the Board of Directors
William Norris Jennings, M.D.
Director
Research analysts who have asked questions during COMMUNITY HEALTH SYSTEMS earnings calls.
Andrew Mok
Barclays
6 questions for CYH
Brian Tanquilut
Jefferies
6 questions for CYH
Benjamin Hendrix
RBC Capital Markets
5 questions for CYH
Joshua Raskin
Nephron Research
5 questions for CYH
Stephen Baxter
Wells Fargo & Company
4 questions for CYH
Albert Rice
UBS
3 questions for CYH
Jason Cassorla
Guggenheim Partners
3 questions for CYH
A.J. Rice
UBS
2 questions for CYH
A.J. Rice
UBS Group AG
1 question for CYH
Charlie Mitchell
Wells Fargo
1 question for CYH
Stephen C. Baxter
Wells Fargo Securities LLC
1 question for CYH
Recent press releases and 8-K filings for CYH.
- Community Health Systems, Inc. (CYH) completed the sale of select assets of its ambulatory outreach laboratory services to Labcorp on December 1, 2025.
- The transaction was completed for approximately $194 million in cash, before certain transaction expenses.
- This sale is expected to result in an estimated pre-tax gain of $107 million ($80 million after tax).
- The strategic divestiture aims to provide broader access to high-quality testing and laboratory services for patients and providers, while allowing CHS-affiliated health systems to focus on core services.
- Community Health Systems (CYH) expects $20 million-$40 million in savings this year and $30 million-$50 million next year from its fully operational ERP system, which became active on January 1st.
- The company anticipates total proceeds from recent divestitures to approach $1 billion, including $35 million for Pennsylvania hospitals, $600 million for Clarksville, $190 million for outreach lab services, and a $90 million contingent payment.
- CYH's primary use of cash flow is to delever the company, aiming to reduce its leverage from 6.7x at the Q2 exit to the mid-5x range in the next few years.
- Professional fees are projected to be up 7% for the full year, with guidance of 8-10%, representing about 5.4% of revenues, while nursing wage increases are expected to be around 4%.
- The company is seeing a rebound in volumes in the third quarter after a Q2 disruption, though surgery volumes are expected to remain soft through the end of the year, particularly in elective outpatient areas for commercially insured patients.
- Subsidiaries of Community Health Systems, Inc. (CYH) have entered into a definitive agreement to sell their 80% ownership interests in two joint ventures.
- These joint ventures own and operate the 270-bed Tennova Healthcare - Clarksville and certain ancillary businesses located in Clarksville, Tennessee.
- The buyer is Vanderbilt University Medical Center (VUMC), which currently holds a minority ownership interest in these joint ventures.
- The total purchase price for the transaction is $600 million, subject to certain net working capital and other adjustments.
- The transaction is expected to close in early 2026, subject to customary regulatory approvals and closing conditions.
- Community Health Systems (CYH) subsidiaries have entered into a definitive agreement to sell their 80% ownership interests in two joint ventures, which own and operate the 270-bed Tennova Healthcare - Clarksville and certain ancillary businesses, to subsidiaries of Vanderbilt University Medical Center (VUMC).
- The sale price for these ownership interests is $600 million, subject to certain net working capital and other adjustments.
- The transaction is expected to close in early 2026, pending customary regulatory approvals and closing conditions, and is part of additional potential divestitures previously discussed by the Company.
- Tenor Health Foundation has signed a definitive agreement to acquire three hospitals in Northeastern Pennsylvania from Community Health Systems (CHS): Wilkes-Barre General Hospital, Regional Hospital of Scranton, and Moses Taylor Hospital, along with associated clinics.
- The acquisition, which includes a combined bed capacity of 677 beds, is contingent on regulatory approval and Tenor finalizing its funding, with a closing anticipated by the fourth quarter of 2025.
- This transaction follows a failed deal with WoodBridge Healthcare in November 2024 and addresses ongoing financial challenges faced by Community Health Systems.
- Community Health Systems (CYH) has entered into a definitive agreement to sell three Pennsylvania hospitals and certain related businesses to affiliates of Tenor Health Foundation.
- The hospitals involved in the sale are the 186-bed Regional Hospital of Scranton, 122-bed Moses Taylor Hospital, and 369-bed Wilkes-Barre General Hospital.
- The transaction is contingent on Tenor Health Foundation finalizing funding and is expected to close within the fourth quarter this year.
- The specific terms of the agreement are not being disclosed.
- Community Health Systems (CYH) reported a 6% year-over-year increase in net revenue for Q3 2025, with adjusted EBITDA reaching $376 million, or $348 million when excluding a $28 million gain from a legal settlement.
- The company tightened its full-year 2025 adjusted EBITDA guidance to a range of $1.50 billion-$1.55 billion and anticipates achieving positive free cash flow for the full year 2025 after adjusting for cash taxes on divestiture gains.
- Leverage at quarter-end decreased to 6.7 times from 7.4x at year-end 2024, following the refinancing of substantially all 2027 maturities with $1.79 billion in new senior secured notes due 2034.
- Same-store net revenue per adjusted admission grew 5.6% year-over-year, driven by rate growth and state-directed payments, while same-store inpatient admissions increased 1.3% and outpatient surgeries declined 2.2%.
- CYH plans to focus future capital investments on expanding access points, including opening three ambulatory surgery centers in Q4 2025 and targeting six to eight more in 2026, along with additional freestanding emergency departments.
- Community Health Systems reported Q3 2025 net revenue growth of 6% year over year and adjusted EBITDA of $376 million, which included a $28 million gain from a legal settlement.
- The company tightened its full-year 2025 adjusted EBITDA guidance to a range of $1.50 billion to $1.55 billion.
- Leverage decreased to 6.7 times at quarter-end from 7.4 times at year-end 2024, following the refinancing of $1.74 billion of 2027 senior secured notes to 2034.
- Despite continued pressure on elective outpatient surgeries, the company saw an improvement in payer mix and expects to achieve positive free cash flow for the full year 2025.
- Strategic initiatives include ongoing divestitures, with $195 million expected from the sale of outreach lab assets in Q4 2025, and investments in ambulatory access points like freestanding emergency departments and ambulatory surgery centers.
- Community Health Systems (CYH) reported Q3 2025 adjusted EBITDA of $376 million, with a 12.2% margin, which included a $28 million gain from a legal settlement. Excluding this gain, adjusted EBITDA was $348 million and the margin was 11.4%, up 20 basis points year over year.
- Net revenue improved 6% year over year , with same-store net revenue also increasing 6.0% year over year, driven by a 5.6% rise in net revenue per adjusted admission. Same-store inpatient admissions grew 1.3%, while surgeries declined 2.2%.
- The company tightened its full-year 2025 adjusted EBITDA guidance to a range of $1.50 billion to $1.55 billion.
- CYH expects to achieve positive free cash flow for the full year 2025 after adjusting for cash taxes on divestiture gains. The company also refinanced most of its 2027 maturities, issuing $1.79 billion in new notes due 2034 and reducing leverage to 6.7 times at quarter-end from 7.4 times at year-end 2024.
- Management is pursuing further divestitures, with some advanced discussions potentially leading to announcements later in 2025. Future capital investments will focus on access points like urgent care, freestanding emergency departments, and ambulatory surgery centers.
- Community Health Systems (CYH) reported Q3 2025 adjusted EBITDA of $376 million, or $348 million when excluding a $28 million gain from a legal settlement, and achieved 6% same store net revenue growth year over year.
- The company tightened its full-year 2025 Adjusted EBITDA guidance to $1.5 billion to $1.55 billion and anticipates achieving positive free cash flow for the full year 2025 after adjusting for cash taxes paid on divestiture gains.
- CYH reduced its leverage to 6.7x from 7.4x at year-end 2024 and refinanced $1.74 billion of 2027 senior secured notes by offering $1.79 billion of 2034 notes.
- Operational highlights for the quarter included a 1.3% increase in same store inpatient admissions but a 2.2% decline in same store surgeries, with an improvement in payer mix.
Quarterly earnings call transcripts for COMMUNITY HEALTH SYSTEMS.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more